RenaissanceRe Holdings Ltd. Common Stock (RNR)

Sales/Maturities of Investments

$18.75B

Quarterly · Period ending: · USD

RNR logo

RNR Sales/Maturities of Investments

Latest reported$18.75B
RNR Quarterly Sales/Maturities of Investments ($191.50M → $18.75B)
High-resolution chart · PNG

RNR sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

RenaissanceRe Holdings Ltd. Common Stock Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
18,752,399,000
17,252,107,000
17,462,729,000
17,399,385,000
11,232,736,000
13,728,905,000
12,049,840,000
12,408,711,000
17,312,441,000
14,604,438,000
0
7,151,401,000
3,129,824,000
11,944,779,000
3,858,425,000
7,401,199,000
6,881,368,000
4,585,587,000
2,957,445,000
3,067,479,000
6,072,246,000
3,597,150,000
0
3,226,490,000
4,679,057,000
3,661,294,000
0
3,298,034,000
4,930,137,000
4,600,808,000
3,154,822,000
3,423,763,000
2,502,676,000
2,318,996,000
2,240,763,000
2,240,851,000
2,510,675,000
2,978,228,000
1,359,446,000
1,613,776,000
2,455,740,000
2,757,415,000
2,314,753,000
2,753,676,000
2,726,497,000
2,232,905,000
1,809,036,000
1,781,244,000
2,113,967,000
2,069,554,000
1,774,441,000
2,101,592,000
2,009,246,000
2,487,518,000
1,930,568,000
1,514,554,000
2,671,367,000
2,361,151,000
1,950,165,000
1,427,432,000
1,273,641,000
1,929,200,000
2,338,423,000
2,349,549,000
3,540,447,000
3,412,235,000
2,713,017,000
3,023,555,000
3,780,130,000
1,754,981,000
3,095,242,000
2,098,370,000
3,885,544,000
2,324,287,000
2,404,158,000
1,018,786,000
179,268,000
1,288,399,000
574,662,000
1,742,339,000
1,564,946,000
1,333,873,000
3,139,296,000
10,379,651,000
6,257,262,000
7,096,550,000
4,707,735,000
4,006,187,000
4,558,456,000
4,326,845,000
2,777,154,000
3,610,791,000
3,766,222,000
2,353,214,000
880,444,000
2,707,037,000
1,484,793,000
870,019,000
923,116,000
809,848,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.